Related Experiment Video
Updated: Aug 17, 2026
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Inflammation and atherosclerosis
Sabine Steffens1, François Mach
1Division of Cardiology, Department of Medicine, University Hospital, Foundation for Medical Research, Geneva, Switzerland.
Insights
Atherosclerosis is an inflammatory disease where leukocytes accumulate. Inflammatory biomarkers like C-reactive protein (CRP) help predict cardiovascular risk, improving prevention and treatment strategies.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Atherosclerosis is recognized as a chronic inflammatory disease.
- Vascular injury from risk factors causes endothelial dysfunction, promoting leukocyte recruitment.
- This leukocyte accumulation is central to atherosclerotic lesion development.
Purpose of the Study:
- To explore the role of inflammatory processes in atherosclerosis.
- To highlight the significance of inflammatory biomarkers in predicting cardiovascular events.
- To discuss the clinical utility of biomarkers like C-reactive protein (CRP).
Main Methods:
- Review of current understanding of inflammatory mechanisms in atherogenesis.
- Analysis of studies linking inflammatory biomarkers to cardiovascular risk.
- Evaluation of the clinical accessibility and power of biomarkers such as CRP.
Main Results:
- Inflammatory processes, including leukocyte recruitment, are key to atherosclerosis.
- Elevated plasma levels of biomarkers (e.g., soluble intercellular adhesion molecule-1, interleukin-6, CRP) indicate future cardiovascular risk.
- C-reactive protein (CRP) has emerged as a powerful and accessible inflammatory marker.
Conclusions:
- Inflammatory biomarkers provide crucial links between cardiovascular risk factors and atherogenesis.
- CRP is a significant predictor of future cardiovascular events.
- Further research is needed to integrate these findings into clinical practice for improved prediction, prevention, and treatment.
Abstract:
It is now generally recognized that atherosclerosis is a chronic inflammatory disease, characterized by overrecruitment of leukocytes (monocytes and T-cells) to the site of inflammation. Vascular injury in response to cardiovascular risk factors promotes endothelial dysfunction, resulting in enhanced adhesion molecule expression and secretion of pro-inflammatory cytokines and chemokines. This, in turn, leads to adherence, migration and accumulation of leukocytes within atherosclerotic lesions. The recent findings on inflammatory processes involved in atherosclerosis development provide important links between risk factors and the mechanisms of atherogenesis. Thus, research interest has increasingly focused on inflammatory biomarkers as means of predicting the risk of future clinical events. Indeed, elevated plasma levels of molecules such as soluble intercellular adhesion molecule-1, interleukin-6 or C-reactive protein (CRP) have been shown to represent inflammatory markers of future cardiovascular risk. Among these, CRP has emerged as the most powerful and accessible for clinical use. A major challenge for future research is to implement these new insights in order to improve strategies for prediction, prevention and treatment of cardiovascular events.
Related Concept Videos
01:38Inflammation
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:30Atherosclerosis I: Introduction
01:28Inflammation: Introduction
01:12Chronic Inflammation: Introduction